{"title":"Exploring Vascular Contributions to Cognitive Impairment: Small-Vessel Disease of White Matter and Microplastics/Nanoplastics.","authors":"Elaine L Bearer","doi":"10.1016/j.ajpath.2025.07.007","DOIUrl":null,"url":null,"abstract":"<p><p>Cognitive impairment due to vascular pathology was recognized by Otto Binswanger in 1894, before Alois Alzheimer presented his findings in 1907. Vascular causes of cognitive impairment are likely due to a range of pathologies that are still, a hundred years later, unknown. Recent epidemiologic evidence from post-mortem human brains reports cases may be afflicted by Alzheimer disease, vascular disease, or both. Although it is well known that hypertension and diabetes affect vasculature throughout the body as well as brain, other types of underlying causes that primarily affect cerebral vessels are understudied. Consensus guidelines exist for histopathologic diagnosis of Alzheimer disease, but are limited for cerebrovascular diseases. Here, first, the anatomy of brain vasculature is reviewed. Next, a schema for categorization of vascular pathologies is proposed, followed by examples that illustrate these pathologies together with stains useful for their detection. Scoring pathologies across many cases according to this schema will subdivide vascular dementias into their underlying, potentially treatable, categories. The recent discovery of microplastics/nanoplastics in the brain and their association with vasculature will have a profound influence on how vascular-pathology-associated cognitive impairment is understood and diagnosed. Going forward, anatomic pathologists will need to apply this categorization to triage types of cerebrovascular pathology and begin to dissect its underlying causes, consequences, and potential treatments.</p>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajpath.2025.07.007","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Cognitive impairment due to vascular pathology was recognized by Otto Binswanger in 1894, before Alois Alzheimer presented his findings in 1907. Vascular causes of cognitive impairment are likely due to a range of pathologies that are still, a hundred years later, unknown. Recent epidemiologic evidence from post-mortem human brains reports cases may be afflicted by Alzheimer disease, vascular disease, or both. Although it is well known that hypertension and diabetes affect vasculature throughout the body as well as brain, other types of underlying causes that primarily affect cerebral vessels are understudied. Consensus guidelines exist for histopathologic diagnosis of Alzheimer disease, but are limited for cerebrovascular diseases. Here, first, the anatomy of brain vasculature is reviewed. Next, a schema for categorization of vascular pathologies is proposed, followed by examples that illustrate these pathologies together with stains useful for their detection. Scoring pathologies across many cases according to this schema will subdivide vascular dementias into their underlying, potentially treatable, categories. The recent discovery of microplastics/nanoplastics in the brain and their association with vasculature will have a profound influence on how vascular-pathology-associated cognitive impairment is understood and diagnosed. Going forward, anatomic pathologists will need to apply this categorization to triage types of cerebrovascular pathology and begin to dissect its underlying causes, consequences, and potential treatments.
期刊介绍:
The American Journal of Pathology, official journal of the American Society for Investigative Pathology, published by Elsevier, Inc., seeks high-quality original research reports, reviews, and commentaries related to the molecular and cellular basis of disease. The editors will consider basic, translational, and clinical investigations that directly address mechanisms of pathogenesis or provide a foundation for future mechanistic inquiries. Examples of such foundational investigations include data mining, identification of biomarkers, molecular pathology, and discovery research. Foundational studies that incorporate deep learning and artificial intelligence are also welcome. High priority is given to studies of human disease and relevant experimental models using molecular, cellular, and organismal approaches.